Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1023 | 1064 | 1093 | 1119 | 1465 | 1970 |
Fund Return | 2.33% | 6.4% | 9.25% | 3.81% | 7.93% | 7.02% |
Place in category | 268 | 98 | 22 | 290 | 24 | 27 |
% in Category | 39 | 15 | 4 | 53 | 7 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF C | 203.57M | 2.46 | 4.59 | 7.82 | ||
B Multistock Swiss Stock Fund CHF A | 203.57M | 2.33 | 3.81 | 7.02 | ||
Multiflex S Carnot Efficient Energc | 106.18M | 3.58 | -1.36 | 2.97 | ||
Popso Suisse Investment Fund S Glob | 86.29M | 3.55 | -0.36 | 2.87 | ||
S CEAMS Quality Switzerland Equityb | 52.13M | 4.29 | 0.86 | 5.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.35B | 6.76 | 5.03 | 6.69 | ||
Raiffeisen Futura Swiss Stock A | 2.07B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHF | 2.01B | 2.43 | 3.56 | 5.81 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.01B | 2.59 | 4.20 | 6.41 | ||
UBAM Swiss Equity AD CHF Inc | 1.72B | 7.99 | -0.55 | 5.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.41 | 89.50 | -0.56% | |
Nestle | CH0038863350 | 5.89 | 92.70 | +0.67% | |
Roche Holding Participation | CH0012032048 | 5.30 | 221.00 | +1.01% | |
Holcim | CH0012214059 | 4.95 | 79.10 | +1.72% | |
UBS Group | CH0244767585 | 4.69 | 25.06 | +0.40% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review